{"schema_version":"1","generated_at":"2026-10-29T04:22:59.051Z","data_as_of":"2026-10-28","url":"https://www.findmykol.com/kol/orit-markowitz","json_url":"https://www.findmykol.com/kol/orit-markowitz/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"orit-markowitz","name":"Orit Markowitz","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma"],"institution":"SUNY Downstate Health Sciences University","institution_url":"https://www.findmykol.com/institution/suny-downstate-health-sciences-university","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1215121538","orcid":"0000-0002-3668-8631","openalex":"A5076370271"},"summary":"Orit Markowitz is a Nonmelanoma Skin Cancer Studies physician affiliated with SUNY Downstate Health Sciences University. OpenAlex indexes 80 publications with 838 citations (h-index 15); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"Orit Markowitz is affiliated with SUNY Downstate Health Sciences University. The public record shows 80 publications with 838 citations (h-index 15), centered on Nonmelanoma Skin Cancer Studies, Cutaneous Melanoma Detection and Management, Optical Coherence Tomography Applications. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 30 companies.","bullets":["Most recent indexed publication: 2026 · Lasers in surgery and medicine","Top research focus: Nonmelanoma Skin Cancer Studies","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 30 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Psoriasis / Psoriatic Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":2,"topics":0,"strength":6},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":1,"topics":1,"strength":4},{"label":"Eczema","therapeutic_area":"Dermatology","trials":1,"topics":0,"strength":3},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Nonmelanoma Skin Cancer Studies","Cutaneous Melanoma Detection and Management","Optical Coherence Tomography Applications","Cancer and Skin Lesions","Dermatology and Skin Diseases"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Ameluz","generic":"Aminolevulinic acid","trials":0,"payments":2,"publications":1,"mentions":3},{"name":"Erivedge","generic":"Vismodegib","trials":0,"payments":1,"publications":1,"mentions":2},{"name":"Dupixent","generic":"Dupilumab","trials":0,"payments":14,"publications":0,"mentions":14}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Galderma Laboratories, L.P.","trials":0,"payments":22,"mentions":22},{"name":"Regeneron Pharmaceuticals, Inc.","trials":0,"payments":15,"mentions":15},{"name":"Sun Pharmaceutical Industries Inc.","trials":0,"payments":10,"mentions":10}]}},"scholarship":{"works_count":80,"cited_by_count":838,"h_index":15,"i10_index":24,"pubmed_count":2,"latest_activity_year":2026,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05963204","title":"A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Galderma R&D","source_url":"https://clinicaltrials.gov/study/NCT05963204","trial_url":"https://www.findmykol.com/trial/NCT05963204"},{"nct":"NCT05265234","title":"Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.","phase":"PHASE4","status":"UNKNOWN","role":"Investigator","sponsor":"OptiSkin Medical","source_url":"https://clinicaltrials.gov/study/NCT05265234","trial_url":"https://www.findmykol.com/trial/NCT05265234"},{"nct":"NCT05135312","title":"Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging","phase":"PHASE4","status":"UNKNOWN","role":"Investigator","sponsor":"OptiSkin Medical","source_url":"https://clinicaltrials.gov/study/NCT05135312","trial_url":"https://www.findmykol.com/trial/NCT05135312"}],"source":"trials"},"payments":{"company_count":30,"program_years":{"first":2021,"last":2025},"rows_total":52,"shown":3,"withheld":49,"rows":[{"payer":"Galderma Laboratories, L.P.","program_year":2025,"amount_usd":17345.75,"payment_count":12,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215121538"},{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":10097.38,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215121538"},{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":863.63,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215121538"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215121538","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":26.5,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":13.3,"drugs":[{"name":"Mometasone Furoate","share_pct":100}],"max_beneficiaries":101},{"class":"RNA Synthetase Inhibitor Antibacterial","setting":"prescribed","share_pct":13.2,"drugs":[{"name":"Mupirocin","share_pct":100}],"max_beneficiaries":99}]},{"area":"Anti-infectives","share_pct":22,"classes_total":4,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":12.5,"drugs":[{"name":"Ketoconazole","share_pct":100}],"max_beneficiaries":67},{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":4.6,"drugs":[{"name":"Valacyclovir","share_pct":100}],"max_beneficiaries":27}]},{"area":"Dermatology","share_pct":21,"classes_total":3,"classes":[{"class":"Corticosteroid","setting":"mixed","share_pct":18,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":52.6},{"name":"Triamcinolone acetonide","share_pct":40.5},{"name":"Fluocinolone Acetonide","share_pct":6.9}],"max_beneficiaries":76},{"class":"Vitamin D Analog","setting":"prescribed","share_pct":1.7,"drugs":[{"name":"Calcipotriene","share_pct":100}],"max_beneficiaries":16}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":2,"shown":2,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"A Prospective, Observational Study Evaluating the Diagnostic Performance of a Newly FDA-Approved Line-Field Optical Coherence Tomography (LC-OCT) in the Detection of Basal Cell Carcinoma.","year":2026,"journal":"Lasers in surgery and medicine","types":["Journal Article","Observational Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42153517/","status":"verified"},{"title":"Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma.","year":2022,"journal":"Lasers in surgery and medicine","types":["Case Reports","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/34289512/","status":"verified"}],"most_cited":{"total":80,"shown":5,"withheld":75,"rows":[{"title":"Introduction to reflectance confocal microscopy and its use in clinical practice","year":2018,"cited_by_count":132,"type":"editorial","source_url":"https://doi.org/10.1016/j.jdcr.2018.09.019"},{"title":"Optical Coherence Tomography in the Diagnosis of Skin Cancer","year":2017,"cited_by_count":87,"type":"article","source_url":"https://doi.org/10.1016/j.det.2017.06.008"},{"title":"Optical Coherence Tomography–Based Optimization of Mohs Micrographic Surgery of Basal Cell Carcinoma: A Pilot Study","year":2013,"cited_by_count":77,"type":"article","source_url":"https://doi.org/10.1111/dsu.12093"},{"title":"Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy.","year":2015,"cited_by_count":59,"type":"article","source_url":"https://openalex.org/A5076370271"},{"title":"A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.","year":2010,"cited_by_count":47,"type":"article","source_url":"https://openalex.org/A5076370271"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Daniel Mark Siegel","coauthored_works":19},{"name":"Amanda Levine","coauthored_works":13,"profile_url":"https://www.findmykol.com/kol/amanda-levine"},{"name":"Michelle Schwartz","coauthored_works":10}],"source":"works"},"similar":[{"name":"Michael Weber","slug":"michael-weber","institution":"SUNY Downstate Health Sciences University","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/michael-weber","json_url":"https://www.findmykol.com/kol/michael-weber/profile.json"},{"name":"Jared Jagdeo","slug":"jared-jagdeo","institution":"SUNY Downstate Health Sciences University","specialty":"Procedural Dermatology","url":"https://www.findmykol.com/kol/jared-jagdeo","json_url":"https://www.findmykol.com/kol/jared-jagdeo/profile.json"},{"name":"John Danias","slug":"john-danias","institution":"SUNY Downstate Health Sciences University","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/john-danias","json_url":"https://www.findmykol.com/kol/john-danias/profile.json"},{"name":"Ellen Ginzler","slug":"ellen-ginzler","institution":"SUNY Downstate Health Sciences University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/ellen-ginzler","json_url":"https://www.findmykol.com/kol/ellen-ginzler/profile.json"},{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"},{"name":"Omid Hamid","slug":"omid-hamid","institution":"The Angeles Clinic and Research Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/omid-hamid","json_url":"https://www.findmykol.com/kol/omid-hamid/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":49,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}